 SOUTH SAN FRANCISCO, Calif., Feb. 07, 2022 GLOBE NEWSWIRE -- VistaGen Therapeutics, Inc . NASDAQ: VTGN, a biopharmaceutical company committed to developing and commercializing innovative medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system CNS disorders, will host a conference call and webcast on Thursday, February 10, 2022 at 2:00 p.m. Pacific Time 5:00 p.m. Eastern Time to report its financial results for its fiscal year 2022 third quarter ended December 31, 2021 and provide a review of recent accomplishments and anticipated upcoming milestones. 